Blue Trust Inc. Purchases 84 Shares of Plexus Corp. (NASDAQ:PLXS)

Blue Trust Inc. grew its holdings in Plexus Corp. (NASDAQ:PLXSFree Report) by 12.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 776 shares of the technology company’s stock after acquiring an additional 84 shares during the quarter. Blue Trust Inc.’s holdings in Plexus were worth $121,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Hennion & Walsh Asset Management Inc. increased its stake in Plexus by 59.0% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 3,445 shares of the technology company’s stock worth $539,000 after acquiring an additional 1,278 shares during the period. USA Financial Formulas acquired a new stake in shares of Plexus during the 4th quarter worth $56,000. Wealth Enhancement Advisory Services LLC raised its stake in Plexus by 17.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 1,779 shares of the technology company’s stock valued at $278,000 after purchasing an additional 261 shares in the last quarter. Diversified Trust Co raised its position in Plexus by 8.3% during the fourth quarter. Diversified Trust Co now owns 3,789 shares of the technology company’s stock valued at $593,000 after purchasing an additional 289 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Plexus by 17.2% during the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company’s stock worth $139,000 after buying an additional 131 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Plexus

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $145.14, for a total value of $496,814.22. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $4,281,775.14. This trade represents a 10.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 4,337 shares of the business’s stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $142.23, for a total value of $616,851.51. Following the sale, the chief executive officer now owns 80,595 shares in the company, valued at approximately $11,463,026.85. The trade was a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,239 shares of company stock worth $2,212,730. 1.76% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on PLXS. Needham & Company LLC boosted their target price on shares of Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Benchmark restated a “buy” rating and set a $165.00 price objective on shares of Plexus in a research report on Wednesday, January 22nd. Stifel Nicolaus began coverage on shares of Plexus in a research note on Tuesday. They set a “hold” rating and a $152.00 target price for the company. StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Finally, KeyCorp started coverage on Plexus in a research note on Tuesday, October 22nd. They set a “sector weight” rating on the stock. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $163.00.

Get Our Latest Research Report on Plexus

Plexus Trading Down 0.3 %

Shares of PLXS stock opened at $141.95 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. The company has a market capitalization of $3.84 billion, a price-to-earnings ratio of 32.94 and a beta of 0.89. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $172.89. The company has a 50-day simple moving average of $159.02 and a two-hundred day simple moving average of $143.55.

Plexus (NASDAQ:PLXSGet Free Report) last released its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. Research analysts anticipate that Plexus Corp. will post 5.97 EPS for the current fiscal year.

Plexus Company Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.